HEADER COMPLEX (PROTO-ONCOGENE/EARLY PROTEIN) 10-JUL-97 1AOT TITLE NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL TITLE 2 PEPTIDE, MINIMIZED AVERAGE STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FYN PROTEIN-TYROSINE KINASE; COMPND 3 CHAIN: F; COMPND 4 FRAGMENT: SH2 DOMAIN; COMPND 5 SYNONYM: SRC HOMOLOGY 2 DOMAIN; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PHOSPHOTYROSYL PEPTIDE; COMPND 11 CHAIN: P SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: BL21; SOURCE 6 GENE: LYSS; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 10 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PRK172; SOURCE 12 EXPRESSION_SYSTEM_GENE: LYSS; SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: HAMSTER POLYOMAVIRUS; SOURCE 15 ORGANISM_TAXID: 10626 KEYWDS SH2 DOMAIN, SIGNAL TRANSDUCTION, PEPTIDE COMPLEX, COMPLEX (PROTO- KEYWDS 2 ONCOGENE-EARLY PROTEIN), COMPLEX (PROTO-ONCOGENE-EARLY PROTEIN) KEYWDS 3 COMPLEX EXPDTA SOLUTION NMR AUTHOR T.D.MULHERN,G.L.SHAW,C.J.MORTON,A.J.DAY,I.D.CAMPBELL REVDAT 3 03-NOV-21 1AOT 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1AOT 1 VERSN REVDAT 1 14-JAN-98 1AOT 0 JRNL AUTH T.D.MULHERN,G.L.SHAW,C.J.MORTON,A.J.DAY,I.D.CAMPBELL JRNL TITL THE SH2 DOMAIN FROM THE TYROSINE KINASE FYN IN COMPLEX WITH JRNL TITL 2 A PHOSPHOTYROSYL PEPTIDE REVEALS INSIGHTS INTO DOMAIN JRNL TITL 3 STABILITY AND BINDING SPECIFICITY. JRNL REF STRUCTURE V. 5 1313 1997 JRNL REFN ISSN 0969-2126 JRNL PMID 9351806 JRNL DOI 10.1016/S0969-2126(97)00283-9 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.PINTAR,M.HENSMANN,K.JUMEL,M.PITKEATHLY,S.E.HARDING, REMARK 1 AUTH 2 I.D.CAMPBELL REMARK 1 TITL SOLUTION STUDIES OF THE SH2 DOMAIN FROM THE FYN TYROSINE REMARK 1 TITL 2 KINASE: SECONDARY STRUCTURE, BACKBONE DYNAMICS AND PROTEIN REMARK 1 TITL 3 ASSOCIATION REMARK 1 REF EUR.BIOPHYS.J. V. 24 371 1996 REMARK 1 REFN ISSN 0175-7571 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE. REMARK 4 REMARK 4 1AOT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171074. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; DQF-COSY; TOCSY; HSQC; REMARK 210 NOESY-HSQC; TOCSY-HSQC; CBCA(CO) REMARK 210 NH; HCCH-TOCSY; XF-NOESY; XF- REMARK 210 TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : OMEGA REMARK 210 SPECTROMETER MANUFACTURER : HOME-BUILT REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR REMARK 210 METHOD USED : DYNAMICAL SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE F 2 -167.89 -54.56 REMARK 500 ALA F 4 26.97 44.55 REMARK 500 GLU F 5 41.13 -179.53 REMARK 500 GLU F 6 -69.08 -162.31 REMARK 500 LYS F 11 69.30 -105.44 REMARK 500 PHE F 24 110.71 57.68 REMARK 500 PRO F 27 -159.14 -78.14 REMARK 500 ARG F 34 158.71 177.58 REMARK 500 ASP F 52 44.22 -85.10 REMARK 500 MET F 53 20.41 -161.80 REMARK 500 LYS F 54 -29.63 -174.73 REMARK 500 LYS F 59 -166.62 -104.22 REMARK 500 ALA F 94 -20.16 93.19 REMARK 500 LEU F 100 -175.23 -49.02 REMARK 500 PRO F 103 -159.92 -78.03 REMARK 500 PRO P 208 -169.97 -78.20 REMARK 500 ILE P 209 31.16 -175.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG F 19 0.09 SIDE CHAIN REMARK 500 ARG F 28 0.22 SIDE CHAIN REMARK 500 ARG F 34 0.14 SIDE CHAIN REMARK 500 ARG F 48 0.13 SIDE CHAIN REMARK 500 ARG F 76 0.31 SIDE CHAIN REMARK 500 ARG F 92 0.29 SIDE CHAIN REMARK 500 ARG F 99 0.20 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: PTR REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: PHOSPHOTYROSINE BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: 3IB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: +3 ILE BINDING SITE. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AOU RELATED DB: PDB REMARK 900 ENSEMBLE DBREF 1AOT F 1 106 UNP P06241 FYN_HUMAN 142 247 DBREF 1AOT P 201 211 UNP P03079 TAMI_POVHA 321 331 SEQADV 1AOT SER F 97 UNP P06241 CYS 238 ENGINEERED MUTATION SEQADV 1AOT SER F 98 UNP P06241 CYS 239 ENGINEERED MUTATION SEQADV 1AOT SER F 104 UNP P06241 CYS 245 ENGINEERED MUTATION SEQRES 1 F 106 SER ILE GLN ALA GLU GLU TRP TYR PHE GLY LYS LEU GLY SEQRES 2 F 106 ARG LYS ASP ALA GLU ARG GLN LEU LEU SER PHE GLY ASN SEQRES 3 F 106 PRO ARG GLY THR PHE LEU ILE ARG GLU SER GLU THR THR SEQRES 4 F 106 LYS GLY ALA TYR SER LEU SER ILE ARG ASP TRP ASP ASP SEQRES 5 F 106 MET LYS GLY ASP HIS VAL LYS HIS TYR LYS ILE ARG LYS SEQRES 6 F 106 LEU ASP ASN GLY GLY TYR TYR ILE THR THR ARG ALA GLN SEQRES 7 F 106 PHE GLU THR LEU GLN GLN LEU VAL GLN HIS TYR SER GLU SEQRES 8 F 106 ARG ALA ALA GLY LEU SER SER ARG LEU VAL VAL PRO SER SEQRES 9 F 106 HIS LYS SEQRES 1 P 11 GLU PRO GLN PTR GLU GLU ILE PRO ILE TYR LEU MODRES 1AOT PTR P 204 TYR O-PHOSPHOTYROSINE HET PTR P 204 24 HETNAM PTR O-PHOSPHOTYROSINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 2 PTR C9 H12 N O6 P HELIX 1 1 ARG F 14 LEU F 22 1 9 HELIX 2 2 LEU F 82 TYR F 89 1 8 SHEET 1 A 2 SER F 46 ARG F 48 0 SHEET 2 A 2 VAL F 58 HIS F 60 -1 N LYS F 59 O ILE F 47 SHEET 1 B 2 ARG F 64 LEU F 66 0 SHEET 2 B 2 GLY F 70 TYR F 72 -1 N TYR F 72 O ARG F 64 LINK C GLN P 203 N PTR P 204 1555 1555 1.31 LINK C PTR P 204 N GLU P 205 1555 1555 1.31 SITE 1 PTR 7 ARG F 34 SER F 36 THR F 38 SER F 44 SITE 2 PTR 7 HIS F 60 TYR F 61 LYS F 62 SITE 1 3IB 5 TYR F 61 ILE F 73 THR F 74 GLY F 95 SITE 2 3IB 5 LEU F 96 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000